Alternative assets and niche micro-caps are experiencing a flurry of activity this week. I'm told that amid shifting Federal Reserve policies and heightened market volatility in 2026, institutional investors are quietly reallocating capital into everything from managed futures to inverse chip ETFs. This is arguably the most significant overhaul in tactical hedging we've seen this year.

Integrated Media Technology (IMTE.US)

The Australian conglomerate, which dabbles in everything from electronic glass to digital assets, has been actively maneuvering. I'm told that in early July 2026, the company secured an extension from Nasdaq to meet its minimum bid price requirement. According to people familiar with the matter, the core business achieved a turnaround with a net income of USD 20.3 million in fiscal 2025, and profitability further improved in the first half of 2026. The stock has rebounded recently as the new corporate secretary settles in.

Cellyan Biotechnology (HKPD.US)

Cellyan Biotechnology is also grappling with Nasdaq compliance. I've learned that the medical distributor, which focuses on the OTC drug supply chain for mainland China, received an additional 180-day grace period in mid-July 2026. However, a delayed 20-F annual report filing announced in August suggests internal audits are still ongoing. The stock has underperformed the broader market this year, and it remains to be seen if they can get back on track before the deadline.

iShares S&P GSCI Commodity-Indexed Trust (GSG.US)

On the commodities front, the inflows are impossible to ignore. Driven by geopolitical tensions and volatile oil prices, the trust's Net Asset Value (NAV) saw a 23.43% surge, according to a 10-Q filed in August 2026. The fund brought in USD 42.5 million in revenue during fiscal 2025. I'm told that following the appointment of a new CEO earlier this year, the fund has been outperforming many traditional fixed-income products.

Also

• Vanguard Intermediate-Term Treasury ETF (VGIT.US) and Vanguard Long-Term Treasury ETF (VGLT.US): I'm told that given the inflation uncertainties in mid-2026, analysts are warning against long-term treasuries, pushing investors toward intermediate havens like VGIT.
• iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD.US): Despite duration risks, the fund continues to attract massive inflows from investors seeking quality fixed-income assets amid the Fed's latest policy tweaks.
• iMGP DBi Managed Futures Strategy ETF (DBMF.US): This trend-following ETF has become a favored diversification tool in 2026, capitalizing on commodity and interest rate movements.
• T-REX 2X Inverse DRAM Daily Target ETF (RAMZ.US): Launched in late July 2026, this is the sector's newest tactical weapon. People familiar with the matter say it was perfectly timed for investors betting on a downturn in the memory chip market.
• enCore Energy Corp. (EU.US): As a player in the energy sector, the company is quietly navigating the broader macro trade environment without making major headlines recently.

This article does not constitute investment advice.